La Rosa Holdings Corp. Extinguishes Majority of Outstanding Warrants Through Exchange Agreements, Strengthening Balance Sheet
July 24, 2025
Client News
-
-
Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials
May 22, 2025
-
Freight Technologies Announces 1-for-4 Reverse Share Split
May 22, 2025
-
Quipt Home Medical Confirms Receipt of Unsolicited Acquisition Proposal
May 21, 2025
-
The VF 8 Reflects a Shift Toward No-Compromise Electric Vehicles
May 21, 2025
-
La Rosa Holdings Corp. Reports Strong Q1 2025 Growth at Celebration, FL and BF Prime, Puerto Rico Offices Driven by Increased Agent Count, Revenue, and Transactions
May 7, 2025
-
OS Therapies Announces Issuance of U.S. Patent #12,239,738 Protecting Commercial Manufacturing Market Exclusivity for OST-HER2 in Rare Pediatric Cancer Osteosarcoma and Full Listeria Cancer Immunotherapy Platform into 2040
May 7, 2025
-
SurgePays Launches Nationwide on AT&T Network with 250,000 SIMs Shipped
April 24, 2025
-
La Rosa Holdings Corp. Announces Authorization of Stock Buyback Program
April 24, 2025
-
NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
April 23, 2025
-
SurgePays Promotes Derron Winfrey to President, Sales and Operations
April 23, 2025
-
La Rosa Holdings Corp. Strategic Collaboration with Lofty to Drive Agent Productivity and Introduce New Recurring Revenue Stream
April 21, 2025
-
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES
April 16, 2025
-
NeuroOne® Issues Letter to Shareholders
April 16, 2025
-
La Rosa Holdings Corp. Reports 119% Year-Over-Year Increase in Revenue to $69.4 Million for Fiscal 2024; Surpassed Initial Revenue Guidance by Approximately $4.4 Million
April 16, 2025
-
Alpha to Announce First Quarter 2025 Financial Results on May 9
April 16, 2025